Cannabis in New York: It’s Not Just About Recreational Use

New York has enacted sweeping changes to its cannabis laws that present opportunities and challenges for the state’s bio/med industry.  The new laws expand the list of conditions treated by medical marijuana, increase the number of caregivers allowed per patient, and permit home cultivation of medical cannabis for patients.  At the same time, federal restrictions on the use of cannabis and its components remain unchanged, limiting the development of drugs and further complicating the nation’s patchwork of cannabis regulation.

Join us and our partner, Barclay Damon, as we explore all things cannabis in New York.  We’ll break down the new regulatory scheme, examine the implications for companies and organizations, and offer a view into the future of cannabis medical applications.  We’ll be joined by industry leader AMRI and professionals in the cannabis investment field to offer their perspectives on what New York’s changes mean for the industry.  You won’t want to miss this timely discussion.